Cannabis enables and enhances the subjective sense of well-being by stimulating the
endocannabinoid system (ECS), which plays a key role in modulating the response to …

The British Association for Psychopharmacology developed an evidence-based consensus
guideline on the management of catatonia. A group of international experts from a wide …

Objective Cannabis and synthetic cannabinoids (SC) are related to several neuropsychiatric
symptoms and disorders, especially psychotic symptoms and disorders. Interestingly …

Background Catatonia presents itself as a complex neuropsychiatric syndrome, giving rise to
various motor, speech, and behavioral challenges. It is noteworthy that approximately 10 …

Periodic catatonia (PC) is a rare type of catatonia syndrome, in which the catatonic phases
often repeat regularly. Between the catatonic periods, the symptoms totally disappear and …

As more states have legalized both recreational and medical marijuana use, the number of
first-time users has risen dramatically. The perception that marijuana is an innocuous drug …

Discussion Case reports of substance-induced catatonia in this age group have included
catatonia secondary to ecstasy 12 and synthetic cannabis. 13 To the best of our knowledge …

Psychiatry is often consulted to evaluate patients admitted to medical settings for issues
such as delirium, agitation, intoxication, refractory medical symptoms, and withdrawal. With …

Catatonia is a syndrome resulting in both severe motor and speech disturbances. Catatonia
in a dual diagnosis of cannabis dependence and depressive disorder is presented. A 28 …